Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
KLAC$129.80-19.85(-13.26%)KLA Declares Regular Cash Dividend4:30:14 PM ETKO$95.75-0.13(-0.14%)DRIVX Moves Toward Final Presale Stage, Unveils Fleet Expansion and Transparent Vesting Strategy4:19:08 PM ETCRWD$217.03-23.95(-9.94%)Why CrowdStrike and cybersecurity stocks got crunched in Thursday's rout4:12:00 PM ETLRCX$192.70-28.58(-12.92%)Lam Research Corporation Announces $25 Billion Share Repurchase Authorization and Declares Quarterly Dividend4:05:00 PM ETSKHY$124.72-18.36(-12.83%)Why SK Hynix Plunged Today4:01:39 PM ETNVDA$182.30-17.99(-8.98%)Is Nvidia Still a Millionaire-Maker Stock?3:51:00 PM ETTSLA$342.27-42.91(-11.14%)SpaceX and Tesla Stock Plunges Have Wiped About $450 Billion in Value Since the Midterms. Is It Time to Buy?3:43:35 PM ETGOOGL$280.99-8.04(-2.78%)Google plans $17 billion Wyoming data center amid rising threats of curbs3:43:13 PM ETNOW$101.40-7.51(-6.90%)Arista Networks vs. ServiceNow: Which Technology Stock Is a Better Buy for 2027?3:43:02 PM ETGOOGL$280.99-8.04(-2.78%)BREAKINGVIEWS-Global muscle will sift puny data center providers3:30:09 PM ETAMD$409.80-78.89(-16.14%)Is AMD Stock a Buy as AI Revenue Soars?3:19:00 PM ETGEV$769.94-62.57(-7.52%)GE Vernova vs. NextEra Energy: Which Industrials Stock Is a Better Buy for 2027?3:17:11 PM ETBRK-A$857,487.54-9,063.79(-1.05%)Berkshire Hathaway Reports Nov. 7 With Its Stock at a Record. Its Cash Pile Is the Number to Watch.3:17:02 PM ETC$118.48+0.68(+0.58%)UPDATE 10-Brent crude jumps, settles up over $3 after tanker attacks3:15:37 PM ETCLX$99.50+0.30(+0.30%)Global Surface Disinfectant Market to Hit US$ 7.5 Bn by 2031, Registering at 7.4% CAGR: Wissen Research3:14:00 PM ETTM$215.73+16.37(+8.21%)ERI’s John Shegerian Describes the Current State of Rare Earth Mineral Recovery at World Remanufacturing Summit in Tokyo3:09:00 PM ETMRVL$135.28-24.63(-15.40%)Marvell Just Dropped 49% in a Month: Is MRVL Stock Hopeless or Ready for a Rebound?3:03:21 PM ETSPCX$123.64-12.19(-8.97%)Bull v. Bear: SPCX Faces Uncertainty as Midterm Results Pressure TSLA Merger3:00:38 PM ETINTC$52.25-6.03(-10.35%)Intel Shares Rise 6% To Intraday High After Key Trading Signal3:00:27 PM ETAMD$409.80-78.89(-16.14%)Advanced Micro Devices vs. Taiwan Semiconductor Manufacturing: The AI Sell-Off Is Exposing a Critical Difference Investors Shouldn't Ignore for 20273:00:02 PM ETHSY$177.43+2.93(+1.68%)Hershey vs. Coca-Cola: Which Consumer Goods Stock Is a Better Buy for 2027?2:51:29 PM ETCRWD$217.03-23.95(-9.94%)CrowdStrike Stock Plummets on AI Regulation Fears2:50:42 PM ETMETA$602.88-26.79(-4.25%)Meta says US users can now video chat with their Muse AI avatar2:48:28 PM ETWFC$84.74-2.72(-3.11%)UNCF Empower Me Tour Continues in Milwaukee, WI, on Nov. 10th with College Readiness Conference, Offering Scholarships and On-Site College Admissions2:43:35 PM ET

APMD · NASDAQ

Apnimed, Inc.

$14.16 -1.06 (-6.96%)

Company overview

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$589M
Employees
65
Headquarters
Cambridge, MA
Website
apnimed.com
CEO
Kevin R. Lind
Listed
July 29, 2026
P/E
0.00
Dividend yield
0.00%

Price chart

13.8219.4024.9730.5436.12
APMD 1D NASDAQ O15.36H15.97L14.65C15.30+0.24 (+1.59%)Vol604.51K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
APMDApnimed, Inc. Press release Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
APMDApnimed, Inc. Press release iOnctura appoints Paul Sekhri as Chair of its Board of Directors GlobeNewswire
APMDApnimed, Inc. Press release Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026 GlobeNewswire
APMDApnimed, Inc. Press release Apnimed, Inc. Reports Inducement Grants under Nasdaq GlobeNewswire
APMDApnimed, Inc. Stock news Apnimed: What We Know Heading Into The Feb PDUFA Seeking Alpha
APMDApnimed, Inc. Press release Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire
APMDApnimed, Inc. Press release Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
APMDApnimed, Inc. Stock news Apnimed, Inc.’s Quiet Period Will End on September 9th (NASDAQ:APMD) Defense World
APMDApnimed, Inc. Stock news Apnimed shares surge on bullish BofA initiation Proactive Investors
APMDApnimed, Inc. Stock news This Agomab Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Benzinga
APMDApnimed, Inc. Press release Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
APMDApnimed, Inc. Stock news AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday's Pre-Market Session Benzinga
See more
FAQ

Questions about Apnimed, Inc.

What does Apnimed, Inc. do?
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
What is APMD's market cap?
Apnimed, Inc. (APMD) is a listed stock with a live quote. The latest market cap on this page is $589M.
Where is Apnimed, Inc. headquartered?
Apnimed, Inc. is headquartered in Cambridge, MA.
How do I get APMD news from the API?
Call GET /v1/news?tickers=APMD. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does APMD news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for APMD, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the APMD price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs